Key Takeaways
- Bloom Energy shares declined approximately 14% Thursday, retreating from the $346 all-time high reached June 22.
- The decline occurred even as the company secured a $1.7 billion investment to supply fuel cells for Nebius’ AI infrastructure.
- Clear Street maintained its Hold rating with a $290 target, suggesting the selloff may represent a tactical entry point.
- Hunterbrook’s short report highlighted vulnerabilities related to scandium procurement from Chinese suppliers.
- The Street consensus leans Moderate Buy, with an average target of $285.45.
Shares of Bloom Energy tumbled approximately 14% during Thursday’s session, with the stock beginning Friday at $205.94. This marks a significant retreat from the $351.28 peak established on June 22.
Interestingly, the decline coincided with news that IDF and Oaktree committed $1.7 billion toward a project utilizing Bloom’s fuel cell technology for Nebius’ artificial intelligence cloud operations.
Clear Street analysts maintained their Hold rating alongside a $290 price objective for BE, suggesting the recent weakness could be transitory rather than indicative of deteriorating business conditions.
“Pullback looks opportunistic,” analysts noted, highlighting the disconnect between current trading levels and their valuation target.
The research firm identified three primary catalysts behind Thursday’s weakness. First, AI-focused equities have broadly corrected since mid-June amid investor scrutiny over whether current valuations accurately reflect anticipated capital expenditures in 2027 and 2028.
Second, evolving regulatory dynamics are creating headwinds. New York recently became the initial state to enact a twelve-month moratorium on data center projects exceeding 50 MW, sparking apprehension about large-scale power deployments.
Third, research published by short-seller Hunterbrook highlighted potential vulnerabilities in Bloom’s scandium supply chain. This rare earth element, critical to the company’s fuel cell production, is predominantly sourced from China, where export restrictions are reportedly intensifying.
Supply Chain Vulnerabilities Under Scrutiny
Clear Street’s analysis indicated that concerns attributed to Bloom’s previous CFO primarily relate to late 2027 and 2028 timeframes, as management works to diversify sourcing across multiple geographies. The bearish research also questioned aspects of Bloom’s financing partnership with Brookfield and highlighted potential timeline extensions for facilities in Wyoming and New Mexico.
Nevertheless, the firm retained its neutral position, indicating that core business drivers remain sound over the longer term.
Institutional Movements and Price Targets
Diversify Wealth Management initiated a position during Q1, acquiring 6,579 shares worth approximately $891,000. Multiple additional institutional buyers expanded their stakes throughout the period, with institutions now controlling 77.04% of BE stock.
Regarding insider transactions, Director John T. Chambers divested 55,000 shares in late May at approximately $297.69 each, totaling more than $16.3 million. Aman Joshi, another insider, sold 8,343 shares on July 1 at $300.37 per share.
Bloom’s latest quarterly results significantly exceeded Wall Street projections. The firm delivered $0.44 in earnings per share versus the $0.12 consensus, while revenue reached $751.05 million compared to expectations of $539.94 million—representing 130.4% year-over-year growth.
Susquehanna elevated its price objective to $298 with a “positive” outlook on July 10. Robert W. Baird confirmed an “outperform” designation with a $310 target on July 9. The aggregate analyst price target currently sits at $250.41, suggesting 38.08% appreciation potential from Friday’s opening price.
BE’s 52-week range spans from $24.04 to $351.28.





